[go: up one dir, main page]

ES8307897A1 - Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo. - Google Patents

Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.

Info

Publication number
ES8307897A1
ES8307897A1 ES511156A ES511156A ES8307897A1 ES 8307897 A1 ES8307897 A1 ES 8307897A1 ES 511156 A ES511156 A ES 511156A ES 511156 A ES511156 A ES 511156A ES 8307897 A1 ES8307897 A1 ES 8307897A1
Authority
ES
Spain
Prior art keywords
immunochemical assay
single incubation
phase
liquid
creatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES511156A
Other languages
English (en)
Other versions
ES511156A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CNA Holdings LLC
Original Assignee
American Hoechst Corp
Hoechst Celanese Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hoechst Corp, Hoechst Celanese Corp filed Critical American Hoechst Corp
Publication of ES511156A0 publication Critical patent/ES511156A0/es
Publication of ES8307897A1 publication Critical patent/ES8307897A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

METODO PARA DETERMINAR LA PRESENCIA DE UN ANTIGENO EN UN MEDIO LIQUIDO SOSPECHOSO DE CONTENERLO. COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE INCUBA UN LIGANTE A ENSAYAR CON UN ANTICUERPO ESPECIFICO INSOLUBILIZADO PARA PRODUCIR UN CONJUGADO ANTICUERPO-LIGANDO INSOLUBILIZADO INICIAL; SEGUNDA, SE SEPARA EL CONJUGADO INICIAL Y EL LIGANTE QUE NO HA REACCIONADO; TERCERA, SE INCUBA EL CONJUGADO INICIAL CON UN ANTICUERPO MARCADO CON ENZIMA, PARA PRODUCIR UN CONJUGADO FINAL ANTICUERPO INSOLUBILIZADO-LIGANDO-ANTICUERPO MARCADO CON ENZIMA; CUARTA, SE SEPARA EL CONJUGADO FINAL Y EL ANTICUERPO MARCADO CON ENZIMA QUE NO HA REACCIONADO; Y POR ULTIMO, SE DETERMINA LA ACTIVIDAD ENZIMATICA YA SEA DEL CONJUGADO FINAL O DEL CONJUGADO MARCADO CON ENZIMA SIN REACCIONAR.
ES511156A 1981-04-13 1982-04-05 Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo. Expired ES8307897A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25360781A 1981-04-13 1981-04-13

Publications (2)

Publication Number Publication Date
ES511156A0 ES511156A0 (es) 1983-08-01
ES8307897A1 true ES8307897A1 (es) 1983-08-01

Family

ID=22960970

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511156A Expired ES8307897A1 (es) 1981-04-13 1982-04-05 Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.

Country Status (7)

Country Link
EP (1) EP0062892B1 (es)
JP (1) JPS57179750A (es)
AT (1) ATE16131T1 (es)
AU (1) AU559469B2 (es)
CA (1) CA1180659A (es)
DE (1) DE3266896D1 (es)
ES (1) ES8307897A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK76983A (da) * 1982-03-05 1983-09-06 Takeda Chemical Industries Ltd Fremgangsmaade og reagens til immunkemisk bestemmelse af humant choriogonadotropin
WO1984004598A1 (en) * 1983-05-06 1984-11-22 Univ Columbia Immunoassay for human chorionic gonadotropin
WO1985000663A1 (en) * 1983-07-25 1985-02-14 Beckman Instruments, Inc. Immunometric assay using polyclonal and monoclonal antibodies and a kit for use therein
GB8328918D0 (en) * 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
US4595661A (en) * 1983-11-18 1986-06-17 Beckman Instruments, Inc. Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
FR2560996B1 (fr) * 1984-03-09 1988-01-15 Commissariat Energie Atomique Procede de dosage immunologique d'antigenes, d'anticorps ou d'haptenes, son utilisation pour le dosage des lipoproteines et de l'a-foetoproteine et trousses de dosage pour la mise en oeuvre de ce procede
US4748111A (en) * 1984-03-12 1988-05-31 Molecular Diagnostics, Inc. Nucleic acid-protein conjugate used in immunoassay
EP0155224A3 (en) * 1984-03-15 1987-05-06 CHROMAGENICS, Inc. Solid-borne complex bearing chromagen responsive functionality for antibody, antigen, receptor, or ligand detection
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
AU590746B2 (en) * 1985-03-06 1989-11-16 Fuji Yakuhin Kogyo Kabushiki Kaisha Method for determining human prolyl 4-hydroxylase by immunoassay
EP0225709B1 (en) * 1985-10-22 1992-05-27 Centocor, Inc. Immunometric assay for high molecular weight carcinoembryonic antigen
DE3633497A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Immunometrisches bestimmungsverfahren
JP2657816B2 (ja) * 1988-03-31 1997-09-30 雪印乳業株式会社 エリスロポエチンの免疫学的測定法
DE3837616A1 (de) * 1988-11-05 1990-05-10 Behringwerke Ag Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aller immunglobulin-klassen und dazu geeignetes mittel

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154599B (nl) * 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
DE2548963C3 (de) * 1975-11-03 1982-03-11 Merck Patent Gmbh, 6100 Darmstadt Verfahren und Mittel zur Bestimmung der Aktivität von Creatinkinase-MB
IL48741A (en) * 1975-12-26 1979-07-25 Rafa Labor Ltd Method for the determination of pregnancy
JPS5347518A (en) * 1976-10-07 1978-04-28 Mochida Pharm Co Ltd Immunologically measuring method
GB1549069A (en) * 1976-12-10 1979-08-01 Erba Farmitalia Enzyme linked immunoassay
FR2385099A1 (fr) * 1977-03-21 1978-10-20 Stago Diagnostica Methode de determination immuno-enzymologique
US4123343A (en) * 1977-06-14 1978-10-31 American Home Products Corporation Purification of glycoproteins and immunization therewith
US4244940A (en) * 1978-09-05 1981-01-13 Bio-Rad Laboratories, Inc. Single-incubation two-site immunoassay
CH642458A5 (en) * 1980-04-25 1984-04-13 Hoffmann La Roche Immunological method
EP0042755B1 (en) * 1980-06-20 1988-08-24 Unilever Plc Processes and apparatus for carrying out specific binding assays
SE8006424L (sv) * 1980-09-12 1982-03-13 Jolla Cancer Res Found Sett att bestemma ett antigen i losning
DE3174064D1 (en) * 1980-10-15 1986-04-17 Takeda Chemical Industries Ltd Method for immunochemical assay and kit therefor

Also Published As

Publication number Publication date
EP0062892A1 (en) 1982-10-20
ATE16131T1 (de) 1985-11-15
DE3266896D1 (en) 1985-11-21
EP0062892B1 (en) 1985-10-16
ES511156A0 (es) 1983-08-01
AU559469B2 (en) 1987-03-12
CA1180659A (en) 1985-01-08
AU8256182A (en) 1982-10-21
JPS57179750A (en) 1982-11-05

Similar Documents

Publication Publication Date Title
ES8307897A1 (es) Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.
ES8802260A1 (es) Un metodo y su correspondiente dispositivo para la determinacion de uno o mas anticuerpos simultaneamente en un liquido biologico
JPS5592693A (en) Determination of ligand
ES8606663A1 (es) Un procedimiento de ensayo inmunometrico para detectar la presencia de al menos dos antigenos en una muestra
AU7974987A (en) Immunoassay based on two ensyme inhibition system
ES8303702A1 (es) "un procedimiento para preparar un vehiculo artificial util para el material de un reactivo de diagnostico".
ES8400147A1 (es) "procedimiento para la determinacion de un antigeno carcinoembrionico".
EP0113075A3 (en) Field immunoassay reaction system, method of immunoassay diagnosis and probe or carrier for use therewith
DE3070938D1 (en) Process and reagent for the immunological determination of enzymes
JPS6463866A (en) Assay and material for detecting antigen related to tumor
DE3473475D1 (en) Process for determining substrate or enzymatic activity
AU657719B2 (en) Methods for determination of an analyte
AU2056088A (en) System and process for a visible assay for analyte
EP0160467A3 (en) Enzyme immunoassay, bibulous support for use therein, and an assay kit
EP0311456A3 (en) Monoclonal antibody to okadaic acids, process for producing the monoclonal antibody, assay reagent for assaying okadaic acids using the monoclonal antibody, and assay method
IE850266L (en) Chromohenic support immunoassay utilizing labelled¹complement components
ES8206038A1 (es) Sistema fisico-bioquimico para la deteccion de sustancias deactividad antigenica.
AU7057387A (en) Liquid single reagent for assays
ES2000227A6 (es) Procedimiento y reactivo para la eliminacion de la perturbacion del descrubrimiento de analitos en muestras de plasma
AU5057785A (en) A method for determining a ligand
FR2611912B1 (fr) Procede de detection et de denombrement d'antigenes particulaires dans un echantillon liquide, notamment des spores de clostridium tyrobutyricum dans le lait
EP0171074A3 (en) A peroxidase and a process of its preparation
EP0173276A3 (en) Method for the determination of substrate or enzyme activity
ES8802545A1 (es) Un metodo para determinar prolil 4-hidroxilasa humana por inmunoensayo enzimatico o radioinmunoensayo
JPS54119026A (en) Simultaneous enzyme immunoassay and kit for practicing the same

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203